Routine high-flow nasal oxygen therapy (HFNOT) following extubation did not improve outcomes compared to standard oxygen ...
In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...
High-flow nasal oxygen therapy showed no benefit after cardiac surgery in a major trial. Learn more about the study.
SAN FRANCISCO -- Starting high-flow oxygen right away for young children with acute hypoxemic respiratory failure didn't help them leave the hospital sooner than standard oxygen therapy, the PARIS-2 ...
High-flow oxygen didn't help patients survive acute hypoxemic respiratory failure better than standard oxygen, the SOHO trial showed. Mortality at day 28 came out an identical 14.6% in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results